APSR2026-1061

 
Late-Breaking
Submitted
Poster Presentation
 
AP13-012
P11
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1245642-46904-POSTER APSR_Amira Sekar Amalia_compressed_433756.pdf
Format: PDF Only
04. Environmental and Occupation Health and Epidemiology
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Amira Sekar Amalia * Universitas Muhammadiyah Yogyakarta Faculty of Medicine Yogyakarta Indonesia
Salsabila Nada Maliha - Universitas Gadjah Mada Faculty of Medicine, Public Health and Nursing Yogyakarta Indonesia
Alya Rahmadani - Universitas Sriwijaya Faculty of Medicine Palembang Indonesia
Muhammad Abi Ghofari Siregar - Universitas Andalas Master Program in Biomedical Science, Faculty of Medicine Padang Indonesia
Yuni Iswati Raharjani - Panembahan Senopati Hospital Department of Pulmonology and Respiratory Medicine Bantul Indonesia
Ayers Gilberth Ivano Kalaij - Universitas Indonesia Faculty of Medicine Jakarta Indonesia
 
 
 
 
 
 
 
 
 
Presenting Author Details
Amira Sekar
Amalia
arsip1.sekar@gmail.com
+6285640664440
Under 30
Indonesia
Original Research
Never-smokers are not safe from lung cancer incidence and mortality: A meta-analysis emphasizing PM2.5 exposure effects
Maximum 25 words
Abstract Content
Although research have been rising, fine particulate matter with aerodynamic diameter 2.5 micrometers or less (PM2.5) - a population-level carcinogenic exposure- role in lung cancer among never-smokers remains debatable. This review evaluated long-term ambient PM2.5 exposure and all lung cancer incidence and mortality among never-smokers or nonsmoking populations, with emphasis on female subgroup and adenocarcinoma incidence.
PubMed, ScienceDirect, and SpringerLink were searched for original human studies reporting long-term PM2.5 exposure and lung cancer outcomes in never-smokers or nonsmoking populations. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs), preferably per 10 micrograms/m3 PM2.5, were pooled using inverse-variance random-effect models through Review Manager 5.4. Risk of bias was assessed using Joanna Briggs Institute cohort criteria. This study was registered in PROSPERO (CRD420261411943).
From 1,808 records, 19 studies met eligibility criteria; 13 cohort studies had predominantly low overall risk of bias. We found that PM2.5 exposure group has higher all lung cancer incidence (HR 1.10; 95% CI 1.04-1.15; I2=48%; p=0.0002) and all lung cancer mortality (HR 1.18; 95% CI 1.10-1.27; I2=52%; p<0.00001). Female-specific analyses showed significant associations for overall lung cancer outcomes (HR 1.11; 95% CI 1.06-1.17; I2=43%) and mortality (HR 1.17; 95% CI 1.08-1.27; I2=0%). The pooled estimates are summarized in Figure 1. Event-total analyses captured 6,870 incident cases and 3,217 deaths, but were descriptive because heterogeneity was high. Adenocarcinoma-specific evidence was clinically relevant but too heterogeneous for pooling.
Long-term ambient PM2.5 exposure is significantly associated with increased all lung cancer incidence and mortality among never-smokers or nonsmoking populations. These findings support air-pollution reduction as a lung cancer prevention priority beyond tobacco control and highlight the need for standardized, sex-specific, and histology-specific evidence.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1245642-37089-APSRFigurePM25_400574.jpeg
JPG or JPEG or PNG format ONLY
Particulate matter 2.5 exposure, lung cancer, never-smokers
maximum 3 keywords and no abbreviations, separated by commas
None.
303